Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Advanced stages of NAFLD were more commonly seen in people whose mothers had obesity or overweight during pregnancy.
On the whole, lean individuals had lower prevalence for these conditions than people with overweight or obesity.
The prevalence of abnormal liver tests in people hospitalized with COVID-19 is higher than previously found.
As with HIV-negative individuals, non-alcoholic fatty liver disease is tied to diabetes and irregular blood lipids in those with HIV.
A fifth of the worldwide population with fatty liver disease consists of lean people.
Normalizing ALT liver enzyme levels is associated with positive long-term outcomes.
The treatment improved ALT liver enzymes, fat accumulation in the liver, insulin resistance and blood lipid levels.
This finding from a recent study applies to those who do not have cirrhosis when they are treated for the virus.
Researchers call for greater use of noninvasive measures of fatty liver disease in this population to identify those at risk.
Interestingly, the drugs themselves, not just the act of curing the virus, were tied to a lower diabetes risk in a recent large study.
Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.
Those who exercise build up less liver fat, which is tied to inflammation that may give rise to cancer.
Having a low CD4 count was also associated with the liver condition in a recent small study.
This is according to an analysis of nearly 5,000 Italians recently treated for the virus.
A recent study analyzed health outcomes among those with decompensated cirrhosis treated with Sovaldi-based regimens.
A BMI of 25 or greater was linked to a reduced likelihood of regression of severe liver fibrosis in a recent study.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.